StockData
SOPHiA GENETICS SA logo

SOPHiA GENETICS SA (SOPH) shareholders

SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 3, 2026Score 4/30
$7.45+0.01 (+0.13%)

Close on Nov 17, 2026Market cap $510.22MP/E –Yield –

Ownership

Who owns SOPHiA GENETICS's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
3 buys · 156 sales
Net sold $5.01M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Generation Investment Management LLP
Joint filing with Generation IM Sustainable Solutions GP III Limited (10.22%), Generation IM Sustainable Solutions Fund III, L.P. (10.22%)
6,789,56010.22%13G (passive) amendmentSep 30, 2024
Akre Capital Management, LLC
Joint filing with Braddock Partners Offshore, LP (5.60%), Braddock Capital Offshore, LLC (5.60%)
3,719,1405.60%13G (passive)Jun 20, 2025

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jurgi CamblongExecutive Chairman, Director3,378,6504.93%Nov 12, 2026
Ross MukenChief Executive Officer, Director880,3911.29%Nov 9, 2026
Well Daan VanChief Legal Officer330,0810.48%Nov 17, 2026
Zhenyu XuChief Scientific Officer537,4930.78%Nov 16, 2026
Philippe MenuChief Medical Officer190,9930.28%Nov 16, 2026
George CardozaChief Financial Officer326,7260.48%Nov 9, 2026
Abhimanyu VermaChief Technology Officer166,8870.24%Oct 7, 2026
Manuela ValenteChief People Officer206,2100.30%Oct 7, 2026
Kevin PuylaertChief Sales Officer147,7320.22%Oct 7, 2026
Kathy L. HibbsDirector90,7420.13%Nov 12, 2026
Troy CoxDirector328,7430.48%Jun 22, 2026
Didier HirschDirector240,2200.35%Jun 22, 2026
Vincent OssipowDirector522,8600.76%Jun 22, 2026
Jean-Michel CosseryDirector206,2120.30%Jun 22, 2026
Tomer BerkovitzDirector––Mar 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Well Daan Van
Chief Legal Officer
Nov 16, 2026Sale(10b5-1 plan)−1,224$7.73$9.46K330,081
Zhenyu Xu
Chief Scientific Officer
Nov 13, 2026Sale(10b5-1 plan)−4,000$7.96$31.82K537,493
Philippe Menu
Chief Medical Officer
Nov 12, 2026Sale(10b5-1 plan)−5,000$7.68$38.40K190,993
Kathy L. Hibbs
Director
Nov 10, 2026Sale(10b5-1 plan)−6,250$7.76$48.48K90,742
Jurgi Camblong
Executive Chairman, Director
Nov 10, 2026Sale(10b5-1 plan)−8,500$7.76$65.95K3,378,650
Well Daan Van
Chief Legal Officer
Nov 9, 2026Sale(10b5-1 plan)−1,411$7.44$10.49K331,305
Ross Muken
Chief Executive Officer, Director
Nov 6, 2026Buy+20,000$6.86$137.19K680,391
George Cardoza
Chief Financial Officer
Nov 6, 2026Buy+20,000$7.06$141.20K326,726
Zhenyu Xu
Chief Scientific Officer
Oct 13, 2026Sale(10b5-1 plan)−4,000$7.18$28.73K541,493
Philippe Menu
Chief Medical Officer
Oct 12, 2026Sale(10b5-1 plan)−5,000$7.26$36.30K195,993
Jurgi Camblong
Executive Chairman, Director
Oct 12, 2026Sale(10b5-1 plan)−8,500$7.26$61.67K3,387,150
Well Daan Van
Chief Legal Officer
Oct 5, 2026Sale(10b5-1 plan)−6,168$8.12$50.10K332,716
Manuela Valente
Chief People Officer
Oct 5, 2026Sale(10b5-1 plan)−4,240$8.13$34.49K206,210
Abhimanyu Verma
Chief Technology Officer
Oct 5, 2026Sale(10b5-1 plan)−5,284$8.12$42.93K166,887
Kevin Puylaert
Chief Sales Officer
Oct 5, 2026Sale−31$7.92$246147,732
Kevin Puylaert
Chief Sales Officer
Oct 5, 2026Sale−185$8.06$1.49K147,763
George Cardoza
Chief Financial Officer
Oct 5, 2026Sale(10b5-1 plan)−1,592$8.10$12.90K306,726
Philippe Menu
Chief Medical Officer
Oct 5, 2026Sale(10b5-1 plan)−7,394$8.13$60.10K200,993
Jurgi Camblong
Executive Chairman, Director
Oct 5, 2026Sale(10b5-1 plan)−40,172$8.13$326.53K3,395,650
Zhenyu Xu
Chief Scientific Officer
Oct 5, 2026Sale(10b5-1 plan)−7,394$8.12$60.07K545,493
Ross Muken
Chief Executive Officer, Director
Oct 5, 2026Sale(10b5-1 plan)−9,838$8.13$79.97K660,391
George Cardoza
Chief Financial Officer
Sep 21, 2026Sale(10b5-1 plan)−774$8.33$6.45K308,318
Ross Muken
Chief Executive Officer, Director
Sep 21, 2026Sale(10b5-1 plan)−422$8.33$3.52K670,229
Zhenyu Xu
Chief Scientific Officer
Sep 14, 2026Sale(10b5-1 plan)−4,000$7.88$31.52K552,887
Philippe Menu
Chief Medical Officer
Sep 14, 2026Sale(10b5-1 plan)−5,000$7.88$39.40K208,387
Well Daan Van
Chief Legal Officer
Sep 11, 2026Sale(10b5-1 plan)−6,168$7.63$47.06K338,884
Jurgi Camblong
Executive Chairman, Director
Sep 10, 2026Sale(10b5-1 plan)−8,500$7.66$65.11K3,435,822
Kathy L. Hibbs
Director
Sep 8, 2026Sale(10b5-1 plan)−6,250$8.13$50.81K96,992
Zhenyu Xu
Chief Scientific Officer
Aug 27, 2026Sale(10b5-1 plan)−10,000$8.91$89.10K556,887
Philippe Menu
Chief Medical Officer
Aug 25, 2026Sale(10b5-1 plan)−5,000$8.68$43.40K213,387
Kathy L. Hibbs
Director
Aug 25, 2026Sale(10b5-1 plan)−6,250$8.68$54.25K103,242
Abhimanyu Verma
Chief Technology Officer
Aug 24, 2026Sale(10b5-1 plan)−5,000$8.80$44.00K172,171
Zhenyu Xu
Chief Scientific Officer
Aug 21, 2026Sale(10b5-1 plan)−5,408$8.40$45.43K566,887
Zhenyu Xu
Chief Scientific Officer
Aug 20, 2026Sale(10b5-1 plan)−4,592$8.41$38.62K572,295
Abhimanyu Verma
Chief Technology Officer
Aug 19, 2026Sale(10b5-1 plan)−5,000$8.20$41.00K177,171
Manuela Valente
Chief People Officer
Aug 19, 2026Option exercise+10,000$3.20$32.00K220,450
Manuela Valente
Chief People Officer
Aug 19, 2026Sale(10b5-1 plan)−10,000$7.94$79.40K210,450
Zhenyu Xu
Chief Scientific Officer
Aug 19, 2026Sale(10b5-1 plan)−10,000$7.94$79.40K576,887
Zhenyu Xu
Chief Scientific Officer
Aug 13, 2026Sale(10b5-1 plan)−4,000$7.52$30.08K586,887
Philippe Menu
Chief Medical Officer
Aug 12, 2026Sale(10b5-1 plan)−5,000$7.52$37.60K218,387
Jurgi Camblong
Executive Chairman, Director
Aug 10, 2026Sale(10b5-1 plan)−8,500$7.61$64.69K3,444,322
Abhimanyu Verma
Chief Technology Officer
Aug 7, 2026Sale(10b5-1 plan)−5,000$7.60$38.00K182,171
Jurgi Camblong
Executive Chairman, Director
Aug 7, 2026Sale(10b5-1 plan)−20,000$7.23$144.60K3,452,822
Zhenyu Xu
Chief Scientific Officer
Aug 7, 2026Option exercise+7,000$3.28$22.96K607,887
Zhenyu Xu
Chief Scientific Officer
Aug 7, 2026Sale(10b5-1 plan)−7,000$7.02$49.14K600,887
Zhenyu Xu
Chief Scientific Officer
Aug 7, 2026Sale(10b5-1 plan)−10,000$7.48$74.80K590,887
Zhenyu Xu
Chief Scientific Officer
Aug 5, 2026Sale(10b5-1 plan)−3,000$7.00$21.00K600,887
Zhenyu Xu
Chief Scientific Officer
Aug 5, 2026Option exercise+3,000$3.28$9.84K603,887
Jurgi Camblong
Executive Chairman, Director
Aug 4, 2026Sale(10b5-1 plan)−20,000$6.92$138.40K3,472,822
Abhimanyu Verma
Chief Technology Officer
Aug 4, 2026Sale(10b5-1 plan)−5,000$6.95$34.75K187,171
Zhenyu Xu
Chief Scientific Officer
Aug 4, 2026Sale(10b5-1 plan)−10,000$6.92$69.20K600,887
Philippe Menu
Chief Medical Officer
Jul 27, 2026Sale(10b5-1 plan)−5,000$5.66$28.30K223,387
Jurgi Camblong
Executive Chairman, Director
Jul 21, 2026Sale(10b5-1 plan)−20,000$6.63$132.60K3,492,822
Jurgi Camblong
Executive Chairman, Director
Jul 20, 2026Option exercise+4,581$3.16$14.48K3,517,403
Jurgi Camblong
Executive Chairman, Director
Jul 20, 2026Sale(10b5-1 plan)−4,581$6.17$28.26K3,512,822
Jurgi Camblong
Executive Chairman, Director
Jul 20, 2026Sale(10b5-1 plan)−19,800$6.32$125.14K3,512,822
Philippe Menu
Chief Medical Officer
Jul 13, 2026Sale(10b5-1 plan)−5,000$5.70$28.50K228,387
Zhenyu Xu
Chief Scientific Officer
Jul 13, 2026Sale(10b5-1 plan)−4,000$5.70$22.80K610,887
Jurgi Camblong
Executive Chairman, Director
Jul 10, 2026Sale(10b5-1 plan)−8,500$5.62$47.77K3,532,622
Jurgi Camblong
Executive Chairman, Director
Jul 7, 2026Sale(10b5-1 plan)−17,685$5.28$93.38K3,541,122

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.88%
1M shares short
Days to cover
2.6
At 0M shares a day
Change since last report
+14.8%
From 1M shares
Short volume, 20 days
26.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of SOPHiA GENETICS's stock actually held short. Settlement fails (shares not delivered on time) peaked at 126,994 shares on Sep 3, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Daan Guido Maria Van Well
Officer
Nov 9, 20261,411$10.07KNov 9, 2026Restricted Stock Units
Jurgi Camblong
Director, Officer
Oct 5, 202665,672$529.97KOct 5, 2026Restricted Stock Units
George Cardoza
Officer
Oct 5, 20261,592$12.85KOct 5, 2026Restricted Stock Units
Manuela Valente
Officer
Oct 5, 20264,240$34.22KOct 5, 2026Restricted Stock Units
Philippe Menu
Officer
Oct 5, 202622,394$180.72KOct 5, 2026Restricted Stock Units
Ross Muken
Director, Officer
Oct 5, 20269,838$79.39KOct 5, 2026Restricted Stock Units
Daan Guido Maria Van Well
Officer
Oct 5, 20266,168$49.78KOct 5, 2026Restricted Stock Units
Zhenyu Xu
Officer
Oct 5, 202619,394$156.51KOct 5, 2026Restricted Stock Units
George Cardoza
Officer
Sep 21, 2026774$6.34KSep 21, 2026Restricted Stock Units
Ross Muken
Director, Officer
Sep 21, 2026422$3.46KSep 21, 2026Restricted Stock Units
Daan Guido Maria Van Well
Officer
Sep 11, 20266,168$46.94KSep 11, 2026Restricted Stock Units
Zhenyu Xu
Officer
Aug 27, 202614,000$119.42KAug 27, 2026Founders Shares
Kathy L. Hibbs
Director
Aug 25, 202618,750$158.44KAug 25, 2026Restricted Stock Units
Zhenyu Xu
Officer
Aug 20, 20266,000$49.68KAug 20, 2026Founders Shares
Manuela Valente
Officer
Aug 19, 202610,000$76.20KAug 19, 2026Exercise of Stock Options

See a number that looks wrong?